TrialBritish journal of clinical pharmacology2007

Pharmacokinetics and safety assessments of high-dose and 4-week treatment with S-3304, a novel matrix metalloproteinase inhibitor, in healthy volunteers.

Timothy G K Mant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.